Aspen Pharmacare Holdings Limited is a global supplier of branded and generic pharmaceuticals and nutritional products in selected territories. Aspen has a proud history of more than 160 years, operating in more than 150 countries across the world. The company supplies a large portfolio of products, with more than 650 branded medicines, specialising in generics and treatments for HIV/AIDS and tuberculosis.
In 2003 Aspen was already the largest generic medicine distributor in South Africa, when Boehringer, Ingelheim and GlaxoSmithKline filed anti-competitive charges against the company. After this, Aspen was granted licenses from the companies to create generic versions of antiretrovirals (ARV) for sale to governments in Sub-Saharan Africa.
The group has 26 manufacturing facilities, with an active presence in 76 countries on all 6 habitable continents. Aspen manufactures approximately 23 billion tablets annually. Aspen shares are up for sale on the Johannesburg Stock Exchange (JSE), where Aspen share price has enjoyed a strong history of growth.
Aspen Shares Growth Driver
Areas of focus for Aspen in the latest financial year included lowering the cost for the anti-coagulant portfolio, improving margins in infant nutritionals, bringing new manufacturing capacity and technologies online, building the third party API business and leveraging intellectual property that Aspen recently made moves to buy. The value created by these initiatives is expected to grow progressively after 2016, with a resultant rise in Aspen share price. Aspen is aiming to earn an additional R2.5 billion from these synergies by the 2019 financial year.
Revenue from customers in Europe and the Commonwealth of Independent States (“Europe CIS”) increased 45% to R10.5 billion. Finished dose form pharmaceutical sales to healthcare providers comprised R6.9 billion of the total sales.
Sales to customers in Latin America, excluding Venezuela, grew 44% to R3.4 billion, and were supported by the infant nutritionals purchase in the prior year. In Venezuela, sales to customers were up 143% to R2.7 billion after adhering to hyper inflationary accounting principles. Revenue in the Asia Pacific business was 5% lower at R8.1 billion whilst EBITA declined by 10% to R1.7 billion.
In Australia sales to customers were 8% lower at R7.2 billion. Sales to customers in Asia accelerated by 39% to R1.3 and were led by strong advances in Japan. In Sub-Saharan Africa, revenue was 1% higher at R2.8 billion.
Aspen Group Investor Tip
Aspen share price has risen from R100 in 2011, to more than R300 in 2016, making Aspen shares a profitable purchase for JSE investors. As of May 2016, the consensus forecast amongst 12 polled investment analysts covering Aspen Pharmacare advised that the company will outperform the market.
The company expects that new acquisitions, capital investments and a branching out into international markets will start to reap dividends for shareholders and investors within a few years. Shareholders will therefore be well advised to hold onto their shares in anticipation for this, whilst new investors should be encouraged to buy Aspen shares.
Aspen Major Shareholders
Saad, SB, Government Employees Pension Fund, Glaxo Group.
Biotech & Pharma
How to buy Aspen Group Shares
Aspen : How to buy Aspen Group Shares Online
We have made it simple to buy JSE listed firm shares online. The easiest way to buy AspenGroup shares or stocks is to; start by submitting the ‘BUY THIS SHARE’ form. Next, one of our experienced and certified stock brokers will personally get in contact with you to discuss your custom stock request. Finally, a stock advisor will confirm the amount of shares you are looking to invest in Aspen Group and assist you with the setup and management of your stock portfolio account.
Here are the steps you must follow to Buy / Purchase Anglo American Platinum Group shares with utmost confidence:
Start by Filling in the BUY THIS SHARE form.
Insert your name, email, telephone number and monthly remuneration.
Then, Indicate the amount you are looking to invest in Aspen Group.
Click the “ INVEST NOW” button
Once we have received your info, a dedicated stock advisor will personally call you back to discuss your personal share request.
Lastly, your newly appointed personal stock advisor will handle all account setups and reporting as stipulated by the financial services board of South Africa (FSB)
Buy Shares with Confidence
Buying JSE shares has never been this convenient and easy. #myfirstshare